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Results: In univariate analysis : The only significant variables between the
02 groups are: age, diabetes, smoking, clearance of creat.
In multivariate analysis, two significant variables: diabetes, the creatinine
clearance.
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Background: Radiocontrast nephropathy is associated with increased mor-
bidity and mortality, particularly in patients with percutaneous coronary inter-
ventions. A number of agents that improve renal circulation have been
clinically tested for prevention of radiocontrast nephropathy, but none of them
has succeeded. Protection of renal tubular cells against oxidative stress is
another approach to avoid radiocontrast nephropathy. Prophylactic effects of
antioxidants such as N-acetylcysteine have been reported by several investiga-
tors, although the effectiveness of these compounds is still a matter of debate.
Ascorbic acid, an antioxidant agent, a safe and not expensive medication,
could be used to prevent radiocontrast nephropathy.
Methods: We conducted a randomized, double-blind, placebo-controlled
trial of ascorbic acid in 202 patients who underwent coronary angiography
and/or intervention. The patients were randomly assigned to receive either oral
Vitamin C (3 g at least 2 hours before the procedure and 2 g in the night and
the morning after the procedure) or placebo, in adjunct to hydration. Serum
creatinine was measured prior to and 48h after coronary angiography. The pri-
mary end-point was the occurrence of CIN, defined as an increase in serum
creatinine ≥0.5 mg/dL (44.2 μmol/L) or ≥25% above baseline at 48h after
exposure to contrast medium.
Results: Complete data on the outcomes were available on 202 patients,
107 of whom had received Vitamine C. There were no significant differences
between the Vitamin C and placebo groups in baseline characteristics, amount
of hydration, or type and volume of contrast used. CIN occurred in 11 out of
107 (10.3%) patients in the Vitamin C group and 20 out of 95 (21.1%)
patients in the placebo group (P=0.032).
Conclusion: There was detectable benefit for the prophylactic administra-
tion of oral Vitamin C over an aggressive hydration protocol in patients
Undergoing Coronary Angiography or Intervention.
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Background: A common argument for identifying SMI in asymptomatic
diabetic patients is to intensify treatment of risk factors and to propose a cor-
onarography for eventual revascularization. However, published data demon-
strating that a prospectively applied screening program improves outcome in
asymptomatic diabetic patient are still lacking.
Aim: Our objective was to determine if patients with SMI+ and coronar-
ography have a better survival than the patients with SMI who did not undergo
coronagraphy.
Methods and results: In our department, we used to screen for SMI in high
risk diabetic patients, following international recommendations. All patients
benefit of treatment of their risk factors following international guidelines.
Since 2000, 913 high risk diabetic patients with normal baseline electro-
cardiography were evaluated to identify patients with SMI, using myocardial
perfusion imaging. SMI prevalence was 18%. Coronarography was done in
94 patients SMI+. There was no difference regarding risk factors between the
group who underwent coronarography and the one who did not. These patients
were followed during a mean period of 6,5 years. Survival analysis was made
for univariate analysis, using Kaplan Meyer methods. Covariables with p-
value < 0.15 at log-rank test were introduced in COX multivariate analysis.
Significant variables were selectioned for final model selection through STEP-
WISE, BACKWARD, FORWARD methods.
79 patients died (8,6%), mainly from cardiovascular diseases (84%). In
univariate analysis, presence of SMI was not associated with total mortality
(p=0,2263) nor cardiovascular mortality (p=0,57). Furthermore, in the group
of patients SMI+, coronarography was not associated with a better survival in
multivariate analysis.
Conclusion: This observational study should argue for intensive cardiovas-
cular risk factors treatment in diabetes in reducing cardiovascular mortality,
with no argument for a benefit from SMI screening
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Background: We investigate the frequency, correlates, and clinical signif-
icance of bleeding complications in diabetic patients (pts) with long-term dual
antiplatelet treatment (DAPLT) after drug-eluting stent (DES) implantation.
Methods: We assessed 610 consecutive diabetic pts (male 80%, mean age
65±9 years) after DES implantation. Five years clinical follow-up (FU),
Variable P- value
AGE 0.030
SEX NS
HTA NS
DIABETES 0.007
SMOKING 0.011
TYPE OF ACS 0.01
BMI NS
CLEARANCE 0.0002
HDL NS
LDL NS
CT NS
TG NS
FE NS
Effect Criteria effect model fit 
tests likelihood ratios
Likelihood ratios tests
2 Log likelihood 
of the model chi-square
chi-deux degrees 
of freedom
Signif.
Constante 92.885 (a) .000 0 .
Smoking 93.919 1.034 1 0.309
Diabetes 97.049 4.164 1 0.041
Age group 99.702 6.817 6 0.338
cclear 100.610 7.725 2 0.021
Type sca 94.859 1.974 1 0.160
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obtained in 587/610 (96%) of them. At the end of FU, 211 (36%) pts were on
single APLT (SAPLT) and 376 (64%) on DAPLT. Bleeding complications
were defined according to PLATO and TIMI definitions
Results: The incidence of bleeding was higher in DAPLT pts (14.6% vs
3.8%, p<0.0001). Minor bleeding according to PLATO occurred in 1.9% of
pts on SAPLT and 11.7% on DAPLT (p<0.0001) and according to TIMI in
2.4% vs 13.6% respectively (p< 0.0001). Major bleeding according to PLATO
presented the 1.9% of pts on SAPLT and 2.9% on DAPLT; according to TIMI
the incidence of major bleeding was 1.4% and 1.1% respectively (p:NS for
both PLATO and TIMI definitions). The incidence of cardiovascular adverse
events was similar between pts with bleeding as compared with those without
bleeding. In a multivariable analysis, smoking was an independent predictor
for overall as well as major bleeding according to PLATO (HR 6.2, 95% CI
1.2-30.4, p=0.024), whereas DAPLT was an independent predictor for overall
and minor bleeding (HR 6.2, 95% CI 2.2-17.3, p<0.0001)
Conclusion: Long-term DAPLT in diabetic patients treated with DES is
associated with higher risk of overall and minor but not major bleeding.
Smoking was an independent predictor for overall bleeding and major
bleeding according to PLATO definitions
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Background: Percutaneous Coronary Intervention (PCI) of Chronic Total
Occlusions (CTO) remains relatively infrequent partly due to the uncertainty
and paucity of data on the likelihood of successful PCI of these lesions. We
sought to examine factors that may predict successful PCI of CTO in order to
improve patient selection and optimisation of conditions for success.
Results: Of 1,509 consecutive PCI of CTO in our institution performed
between 2004 and 2011, the median age was 63 and 86% were male. The suc-
cess rate of PCI of CTO was 71%. Significant univariate correlations to suc-
cessful PCI were operator experience (r=0.08, p=0.002), and tapered
morphology (r=0.1, p=0.0001), while factors that contributed to failure were
age (r=–0.06, p=0.02), lesion length (r=–0.2, p<0.0001), no visible stump
(r=–0.08, p=0.001), calcification (r=–0.15, p=0.04), any tortuosity (r=–0.05,
p=0.046), previous MI (r=–0.1, p=0.0001) and previous CABG (r=–0.12,
p<0.001). Table 1 shows the significant predictors in terms of their odds ratios
of successful PCI of CTO in a multivariable logistic model which also
adjusted for age, sex, radial access, femoral access, operator experience, pre-
vious attempts, lesion length, stump visibility, calcification, tortuosity and pre-
vious CABG. Radial access was as good as femoral access in terms of
successful PCI of CTO (OR 1.1, p=0.7 vs OR 1.0, p=–0.8). 
Conclusions: In this contemporary series, age, lesion length, operator
experience, stump visibility, tapered morphology, calcification, tortuosity, pre-
vious MI and previous CABG affect successful PCI of CTO.
Table 1 – Selected significant predictors from multivariable model 
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Aims: To assess middle term outcomes according to SYNTAX score and
rates of delayed surgical/bleeding events after unprotected left main (LM) cor-
onary artery (ULMCA) PCI in an unselected patients population.
Methods: Consecutive patients treated by PCI for ULMCA were
included among a single center 3508 PCI database within 36 months. Syntax
scores were calculated, post discharge extracardiac surgery or hemorrhage
were recorded during follow-up as clinical outcomes (Death, TVR,
MACCE=cardiovascular death+MI+stroke+TLR).
Results: 102 (3.6%) patients underwent PCI of the LM, including 21 pro-
tected LM. Among the 81 patients with PCI of ULMCA, mean age was
65±13, 27% had urgent PCI for AMI or cardiogenic shock, 61% had DES.
SYNTAX score was 28±14 in mean and ≤22 in 30 (37%), 23 to 32 in 22
(27%) and ≥33 in 29 (36%) patients.
At 30±11 months follow up (98% of the patients), death occurred in
24 patients (30%), TVR in 16 (20%) and MACCE in 35 (43%). Clinical
events according to the SYNTAX score are shown in figure. No cardiovas-
cular death occurred in patients with syntax ≤22. MACCE rates were signifi-
cantly lower when DES were used (24% vs. 64%, p<0.05) and in case of non-
urgent PCI (36% vs. 71%, p<0.05).
During follow-up, 20 (25%) and 12 (15%) patients underwent unplanned
extracardiac surgery and/or hemorrhage, leading to antiplatelet withdrawal in
31% of the cases.
Conclusions: In unselected patients treated by PCI of ULMCA with
Syntax score ≤22, outcomes were found to be excellent with no cardiovascular
death observed at 30 months. DES and non-urgent PCI were associated with
a better prognosis. One patient out of three underwent unplanned extracardiac
surgery or hemorrhage during follow up.
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OR or successful 
PCI of CTO 
 95% CI  P value
Age (per yr increase)  0.98  0.98, 0.99  0.03
Lesion length 
(per 1 mm increase
 0.97  0.97, 0.98  <0.001
Operator experience 
(per 50 cases increase)
 1.13  1.06, 1.19  <0.001
Stump visible  1.51  1.12, 2.06  0.008
Tapered morphology  1.36  1.03, 1.78  <0.001
Calcification  0.74 0.65, 0.84  <0.001
Any tortuosity  0.72  0.53, 0.98  0.04
Previous MI  0.67  0.50, 0.88  0.005
Previous CABG  0.44  0.29, 0.68  <0.001
Figure: 30-months outcomes according to SYTAX score
